These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23835090)

  • 1. Impact of cladribine therapy on changes in circulating dendritic cell subsets, T cells and B cells in patients with multiple sclerosis.
    Mitosek-Szewczyk K; Tabarkiewicz J; Wilczynska B; Lobejko K; Berbecki J; Nastaj M; Dworzanska E; Kolodziejczyk B; Stelmasiak Z; Rolinski J
    J Neurol Sci; 2013 Sep; 332(1-2):35-40. PubMed ID: 23835090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cultured lymphocytes' mitochondrial genome integrity is not altered by cladribine.
    Järvinen E; Suomi F; Stewart JB; Guala D; Valori M; Jansson L; Nieminen J; McWilliams TG; Tienari PJ
    Clin Exp Immunol; 2023 Dec; 214(3):304-313. PubMed ID: 37860849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained effects on immune cell subsets and autoreactivity in multiple sclerosis patients treated with oral cladribine.
    Holm Hansen R; von Essen MR; Reith Mahler M; Cobanovic S; Sellebjerg F
    Front Immunol; 2024; 15():1327672. PubMed ID: 38433828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cladribine to Treat Relapsing Forms of Multiple Sclerosis.
    Giovannoni G
    Neurotherapeutics; 2017 Oct; 14(4):874-887. PubMed ID: 29168160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment response.
    Teschner VE; Fleck AK; Walter C; Schwarze AS; Eschborn M; Wirth T; Steinberg OV; Schulte-Mecklenbeck A; Lu IN; Herrera-Rivero M; Janoschka C; Lünemann JD; Schwab N; Meyer Zu Hörste G; Varghese J; Gross CC; Pul R; Kleinschnitz C; Mader S; Meinl E; Stoll M; Wiendl H; Klotz L
    Ther Adv Neurol Disord; 2023; 16():17562864231211077. PubMed ID: 38084102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experience in the use of cladribine for the treatment of patients with highly active forms of multiple sclerosis in the Moscow region].
    Yakushina TI; Yakushin DM; Lizhdvoy VY; Belova YA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(6):74-79. PubMed ID: 39072570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characterization of peripheral blood cellular populations in relation to Ascaris Lumbricoides infection in rural areas of Bolívar].
    Lozano A; Marrugo V; Alvarado JC; Hernandez K; Caballero KL; Acevedo N; Zakzuk J; Caraballo L
    Rev Alerg Mex; 2024 Feb; 71(1):69. PubMed ID: 38683086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant Dendritic Cell Subsets in Patients with Myasthenia Gravis and Related Clinical Features.
    Song Y; Xing C; Lu T; Liu C; Wang W; Wang S; Feng X; Bi J; Wang Q; Lai C
    Neuroimmunomodulation; 2023; 30(1):69-80. PubMed ID: 36780882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The reproducibility of dendritic cell and T cell counts to a 30-min high-intensity cycling protocol as a tool to highlight overtraining.
    Baker C; Piasecki J; Hunt JA; Hough J
    Exp Physiol; 2024 Mar; 109(3):380-392. PubMed ID: 38063067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of dendritic cell subsets in the tumor microenvironment by multiplex immunohistochemistry.
    van der Hoorn IAE; Martynova E; Subtil B; Meek J; Verrijp K; Textor J; Flórez-Grau G; Piet B; van den Heuvel MM; de Vries IJM; Gorris MAJ
    Eur J Immunol; 2024 Jan; 54(1):e2350616. PubMed ID: 37840200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin administration provokes the activity of dendritic reticular cells in the seminal vesicle of Soay ram during the non-breeding season.
    Abd-Elhafeez HH; Hassan AHS; Hussein MT
    Sci Rep; 2021 Jan; 11(1):872. PubMed ID: 33441634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Dysregulation of the Monocyte-Dendritic Cell Interplay Is Associated with In-Hospital Mortality in COVID-19 Pneumonia.
    Galati D; Mallardo D; Nicastro C; Zanotta S; Capitelli L; Lombardi C; Baino B; Cavalcanti E; Sale S; Labonia F; Boenzi R; Atripaldi L; Ascierto PA; Bocchino M
    J Clin Med; 2024 Apr; 13(9):. PubMed ID: 38731010
    [No Abstract]   [Full Text] [Related]  

  • 13. Beyond the B-cell as a treatment target in multiple sclerosis.
    Giovannoni G; Hawkes CH; Lechner-Scott J; Levy M; Yeh EA
    Mult Scler Relat Disord; 2023 Jul; 75():104786. PubMed ID: 37295263
    [No Abstract]   [Full Text] [Related]  

  • 14. Human Dendritic Cell Subset Isolation by Magnetic Bead Sorting: A Protocol to Efficiently Obtain Pure Populations.
    Flórez-Grau G; Escalona JC; Lacasta-Mambo H; Roelofs D; Bödder J; Beuk R; Schreibelt G; De Vries JIM
    Bio Protoc; 2023 Oct; 13(20):e4851. PubMed ID: 37900109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A tale of race and B cells in multiple sclerosis.
    Orlando CM; Amezcua L
    Nat Rev Neurol; 2024 Jan; 20(1):5-6. PubMed ID: 37990136
    [No Abstract]   [Full Text] [Related]  

  • 16. A case report of cladribine-induced IgG4-associated liver injury.
    Biolato M; Bianco A; Giustiniani MC; Mirabella M; Pompili M
    Acta Neurol Belg; 2024 Apr; ():. PubMed ID: 38587719
    [No Abstract]   [Full Text] [Related]  

  • 17. Both cladribine and alemtuzumab may effect MS via B-cell depletion.
    Baker D; Herrod SS; Alvarez-Gonzalez C; Zalewski L; Albor C; Schmierer K
    Neurol Neuroimmunol Neuroinflamm; 2017 Jul; 4(4):e360. PubMed ID: 28626781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells.
    Ceronie B; Jacobs BM; Baker D; Dubuisson N; Mao Z; Ammoscato F; Lock H; Longhurst HJ; Giovannoni G; Schmierer K
    J Neurol; 2018 May; 265(5):1199-1209. PubMed ID: 29550884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis.
    Baker D; Marta M; Pryce G; Giovannoni G; Schmierer K
    EBioMedicine; 2017 Feb; 16():41-50. PubMed ID: 28161400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cladribine to treat disease exacerbation after fingolimod discontinuation in progressive multiple sclerosis.
    Alvarez-Gonzalez C; Adams A; Mathews J; Turner BP; Giovannoni G; Baker D; Schmierer K
    Ann Clin Transl Neurol; 2017 Jul; 4(7):506-511. PubMed ID: 28695150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.